Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Purity | ≥98% |
---|---|
Formula | C25H39H7O8 |
Formula Wt. | 565.63 |
Synonym | EHIPA. |
Solubility | Soluble in water (2 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
α2-adrenergic agonist.
PDE3 inhibitor.
Peptide, GnRH analog; GnRH agonist.
Diterpene cafestol derivative found in coffee b...
Flavanol originally found in Camilla (green tea...
Alkaloid compound found in Corydalis.
Furanolactone found in Citrus.
Triazine, melamine derivative, insect growth re...
CDK2 inhibitor
NSAID; COX-1/2 and PDE inhibitor.
JAK1/2/3 inhibitor.
NSAID; COX-1/2 inhibitor.
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...
Inert clozapine analog, activates specialized G...
14-α demethylase inhibitor.
ITC, used as chiral agent.
Impurity of diclofenac
Potential ATP-sensitive K+ channel blocker, pot...
Peptide; α4β1 integrin activator.
Synthetic compound related to sulforaphane.